Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients | NEJM - discu.eu

Linking pages

Linked pages

Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2208375 145 comments
Remdesivir for the Treatment of Covid-19 — Final Report | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2007764 55 comments
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results | NEJM https://www.nejm.org/doi/10.1056/nejmoa2023184 54 comments
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2015301 6 comments
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2107934 5 comments
Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2205650 3 comments

Related searches:

Search whole site: site:www.nejm.org

Search title: Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients | NEJM

See how to search.

Submit link to: